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Abstract
Background: Kynurenine aminotransferase (KAT) catalyzes the transamination of kynunrenine to kynurenic acid 
(KYNA). KYNA is a neuroactive compound and functions as an antagonist of alpha7-nicotinic acetylcholine receptors 
and is the only known endogenous antagonist of N-methyl-D-aspartate receptors. Four KAT enzymes, KAT I/glutamine 
transaminase K/cysteine conjugate beta-lyase 1, KAT II/aminoadipate aminotransferase, KAT III/cysteine conjugate 
beta-lyase 2, and KAT IV/glutamic-oxaloacetic transaminase 2/mitochondrial aspartate aminotransferase, have been 
reported in mammalian brains. Because of the substrate overlap of the four KAT enzymes, it is difficult to assay the 
specific activity of each KAT in animal brains.
Results: This study concerns the functional expression and comparative characterization of KAT I, II, III, and IV from 
mice. At the applied test conditions, equimolar tryptophan with kynurenine significantly inhibited only mouse KAT I 
and IV, equimolar methionine inhibited only mouse KAT III and equimolar aspartate inhibited only mouse KAT IV. The 
activity of mouse KAT II was not significantly inhibited by any proteinogenic amino acids at equimolar concentrations. 
pH optima, temperature preferences of four KATs were also tested in this study. Midpoint temperatures of the protein 
melting, half life values at 65°C, and pKa values of mouse KAT I, II, III, and IV were 69.8, 65.9, 64.8 and 66.5°C; 69.7, 27.4, 3.9 
and 6.5 min; pH 7.6, 5.7, 8.7 and 6.9, respectively.
Conclusion: The characteristics reported here could be used to develop specific assay methods for each of the four 
murine KATs. These specific assays could be used to identify which KAT is affected in mouse models for research and to 
develop small molecule drugs for prevention and treatment of KAT-involved human diseases.
Background
The aminotransferase capable of catalyzing the transami-
nation of kynurenine to kynurenic acid (KYNA) using
various co-substrates, has commonly been termed
kynurenine aminotransferase (KAT). KYNA is the only
known endogenous antagonist of the N-methyl-D-aspar-
tate subtype of glutamate receptors[1-4]. It is also an
antagonist of the α7-nicotinic acetylcholine receptor[5-
8]. In addition, KYNA is identified as an endogenous
ligand for an orphan G-protein-coupled receptor
(GPR35) that is predominantly expressed in immune
cells[9]. Abnormal concentration of KYNA in cerebrospi-
nal fluid/brain tissue has been observed in patients with
mental and neurological disorders, including the Hun-
tington's disease, Alzheimer's disease, schizophrenia,
multiple sclerosis and others (for a review see [10]).
These data suggest that KYNA, acting as an endogenous
modulator of glutamatergic and cholinergic neurotrans-
mission, may be functionally significant in the develop-
ment and progression of these diseases. In addition to its
roles as an excitatory amino acid and α7-nicotinic acetyl-
choline antagonist, KYNA is also involved in the control
o f  t h e  c a r d i o v a s c u l a r  f u n c t i o n  b y  a c t i n g  a t  t h e  r o s t r a l
ventrolateral medulla of the central nervous system
(CNS)[11]. Spontaneously hypertensive rat, the most
widely used animal model for studying genetic hyperten-
sion, is associated with abnormally low KYNA levels in
the area of CNS which controls physiological blood pres-
sure[12,13].
KYNA is produced enzymatically by irreversible
transamination of kynurenine, the key intermediate in
the tryptophan catabolic pathway. In humans, rats and
mice, four proteins arbitrarily named KAT I, II, III and IV,
have been considered to be involved in KYNA synthesis
in the CNS[14-20]. KAT I is identical to glutamine
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transaminase K (GTK) and cysteine conjugate beta-lyase
(CCBL) 1; KAT II is identical to aminoadipate amin-
otransferase (AADAT); KAT III is identical to CCBL 2;
and KAT IV is identical to glutamic-oxaloacetic transam-
inase (GOT) 2 and mitochondrial aspartate aminotrans-
ferase (ASAT). Although the involvement of these
enzymes in brain KYNA production has been discussed,
their specific roles in brain KYNA synthesis remain to be
established.
Among the individual mammalian KATs, KAT I and
KAT III share similar genomic structure and high
sequence identity [18] and therefore likely have over-
lapped biological functions. An increase in KAT I and
KAT III expression was observed in kat-2 -/- mice brain,
suggesting that KAT I and KAT III expression compen-
sated for the loss of KAT II [18]. This also might explain
why phenotypes such as the hyperactivity and abnormal
motor coordination in the kat-2 -/-  mice were res-
cued[7,18,21]. These data suggest the importance of
mammalian KAT I and KAT III in maintaining KYNA
level in kat-2 -/- mouse brain.
There have been many studies dealing with the bio-
chemical characteristics of mammalian KAT I and KAT
II[15,17,22-26]. The crystal structures of human KAT I
[27,28] and its homologues, glutamine-phenylpyruvate
aminotransferase from Thermus thermophilus HB8 [29]
and KAT from a mosquito, Aedes aegypti [30], have been
determined. The crystal structure of human KAT II
[26,31,32] and its homologues from Pyrococcus horikoshii
[33] and Thermus thermophilus [34] have also been
determined. The biochemical function and structural
characteristics of mouse KAT (mKAT) III have been
determined[20]; and there have been a number of studies
concerning the biochemical characterization of KAT
IV[19,35-38]. In this study, we functionally expressed
mKAT I, II, III, and IV in the same expression system,
purified their recombinant proteins, investigated their
pH optima, temperature preferences, and identified spe-
cific inhibitors for each individual mKAT. These proper-
ties of mKATs I, II, III, and IV will help develop specific
assays for the four enzymes, which could be used to iden-
tify which KAT is affected in mouse disease models."
Results
Biophysical properties of mKATs
SDS-PAGE analysis showed single band for each recom-
binant protein (not shown). Freezing and thawing did not
alter the activity of the isolated enzymes. mKAT I showed
maximum activity at 60 to 70°C (Fig. 1a), mKAT II
showed maximum activity at 50°C (Fig. 1a), both mKAT
III and mKAT IV (Fig. 1b) showed maximum activity at
60°C. The fact that all four enzymes showed high activity
at 50°C, with mKAT I and IV functioning at 70°C, indi-
cates they are resistant to heating. Tm (midpoint tempera-
ture of the protein melting) values of mKAT I, II, III, and
IV are 68.8 ± 1.2, 65.9 ± 0.5, 64.8 ± 0.7, 66.5 ± 0.5°C,
respectively. Fig. 2 shows the fitting curve of each enzyme
during the denaturation by heat treatment. The calcu-
lated half life in first order kinetics (t1/2) values of mKAT
I, II, III, and IV at 65°C are 69.7 ± 8.8, 27.4 ± 3.2, 3.9 ± 0.1
and 6.5 ± 0.7 min, respectively (Fig. 3).
mKAT I, II, and IV all had a broad optimum pH range,
while mKAT III had a relatively narrow optimum pH
range. pH profiles of the four KAT proteins are all bell-
shaped curves (Fig. 4). mKAT I and III showed maximum
activity at pH 9 (Fig. 4a & 4c), mKAT II showed maxi-
mum activity at pH 7 to 8 (Fig. 4b), and mKAT IV (Fig.
4d) showed maximum activity at pH 8. The calculated
pKa values of mKAT I, mKAT II, mKAT III, and mKAT
IV are 7.6 ± 0.2, 5.7 ± 0.1, 8.7 ± 0.3 and 6.9 ± 0.1, respec-
tively. The calculated pKb values of mKAT I, mKAT II,
mKAT III, and mKAT IV are 10.3 ± 0.2, 5.7 ± 0.1, 8.7 ±
0.2 and 6.9 ± 0.1, respectively. Comparison of the pH
optima of mKAT II and human KAT II, indicates that the
pH o pt im um  o f  mKA T II is  a ppa r e n t ly s hift ed t owa r d
more acidic conditions, as it showed higher activity at pH
6  t h a n  a t  p H  9 ,  i n  c o n t r a s t  t o  h u m a n  K A T  I I  w h i c h
showed much higher activity at pH 9 than at pH 6. The
activity of mKA T II at pH 6 is not shared by the other
three mKATs, which suggests a possible test for the spe-
cific activity of mKAT II. The pH optimum of mKAT I is
similar to that of human KAT I [17], while the optimum
of mKAT III expressed in Escherichia coli is the same as
that of mKAT III expressed in insect cells[20].
Substrate specificities of mKAT IV
mKAT IV was tested for aminotransferase activity
towards 24 different amino acids using α-ketoglutarate
(or oxaloacetate for glutamate), as a primary amino group
acceptor. The enzyme showed the highest activity with
aspartate and glutamate as substrates, but also showed
activity with other amino acids, including some aromatic
amino acids [phenylalanine, kynurenine, tryptophan, 3-
hydroxy-DL-kynurenine (3-HK) and tyrosine] and sulfur
containing amino acids (methionine and cysteine) (Fig.
5).
Effects of other amino acids on four mKATs
The inhibition of each of 23 other amino acids was inves-
tigated by incorporating them individually into reaction
mixtures containing 5 mM kynurenine and each of the
mKATs in turn. Of these, tryptophan, phenylalanine, glu-
tamine, and cysteine were observed to inhibit mKAT I
activity; methionine, glutamine, histidine, cysteine, leu-
cine, and phenylalanine to inhibit mKAT III activity; and,
aspartate and glutamate to inhibit around 80% and
tyrosine, phenylalanine, tryptophan, glutamine, cysteine,
asparagine, and histidine to inhibit 20 - 40% of mKAT IVHan et al. BMC Biochemistry 2010, 11:19
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activity. Although aminoadipate, lysine, 3-HK show inhi-
bition of mKAT II activity, none of them inhibit more
than 30% activity (Fig. 6).
KAT activities of mouse brain crude proteins
The brain crude proteins showed KAT activity with all 16
tested α-ketoacids (Fig. 7). In particular, the crude pro-
teins showed high activity with glyoxylate, a good co-sub-
strate for mKAT I and III; and with α-ketoglutarate, a
good substrate for mKAT II and IV. These results are
consistent with previous studies which demonstrated that
mouse brains have all four KAT enzymes[18-20].
Based on the aforementioned results of amino acid
inhibition study, we used methionine, tryptophan, amin-
oadipate, and aspartate to test inhibition of KAT activity
in mouse brain crude protein. We found that aspartate
inhibited 48% KAT activity in the crude protein at pH 7.5
using α-ketoglutarate as a co-substrate (Fig. 8a) and 30%
activity at pH 9 (Fig. 8b) using glyoxylate as a co-sub-
strate. Tryptophan inhibited 26% and methionine inhib-
ited 15% KAT activity at pH 9 using glyoxylate as a co-
substrate (Fig. 8b). Aminoadipate did not significantly
inhibit KAT activity at either pH 9 or pH 7.5.
Discussion
The identity of ASAT with KAT was first reported in E.
coli [39], and when later it was found that mitochondrial
ASATs in mice, rats, and humans had KAT activity, it was
also named KAT IV[19]. In this study, we showed mKAT
IV has high transamination activity towards glutamate
and aspartate, and detectable activity towards phenylala-
nine, tyrosine, cysteine, tryptophan, 3-HK, methionine,
kynurenine, and asparagine. KAT IV was considered as a
major player for the formation of KYNA in mouse, rat
and human brains[19]. Our results certainly show that
mouse brain protein extract has high mKAT IV activity as
evidenced by the strong aspartate inhibition of the KYNA
formation in the reaction mixture. High KAT activity is
detected in mouse brain crude proteins using α-ketoglu-
tarate as a co-substrate at neutral pH condition, and as
Figure 1 Effect of temperature on enzyme activity. The activities of recombinant mKATs at different temperatures. a) mKAT I and mKAT II, b) mKAT 
III and mKAT IV.
Figure 2 The absorbance changes at 280 nm of four mKAT proteins after heat treatment. a, mKAT I; b, mKAT II; c, mKAT III, and d, mKAT IV.Han et al. BMC Biochemistry 2010, 11:19
http://www.biomedcentral.com/1471-2091/11/19
Page 4 of 10
mKAT IV is majorly responsible for this KAT activity, its
contribution in brain KYNA synthesis has yet to be
excluded. A gene knock-out study in animal models could
address this question definitively.
KYNA is a metabolite in the kynurenine pathway, a
major pathway in tryptophan metabolism, and its forma-
tion from tryptophan is a complicated process involving a
number of enzymes [16,40]. The overall process leading
to the formation of KYNA includes oxidation of trypto-
phan to formylkynurenine catalyzed by tryptophan 2,3
dioxygenase and indoleamine 2,3 dioxygenase; hydrolysis
of formylkynurenine to kynurenine catalyzed by kynure-
nine formamidase; and transamination of kynurenine to
KYNA catalyzed by four KATs. Alternatively, kynurenine
could be oxidized by kynurenine 3-monooxygenase to
f o r m  3 - H K  o r  h y d r o l y z e d  b y  k y n u r e n i n a s e  t o  f o r m
anthranilic acid. The mouse brain crude extract not only
consists of four KAT enzymes but also other proteins
involved in the kynurenine pathway. In our preliminary
studies, when we tested KAT activity at pH 7.5, we
observed the formation of 3-HK and anthranilic acid
[confirmed using standard compounds (not shown)]; we
also noticed that KYNA formation was increased by add-
ing tryptophan to the reaction mixture. This is perhaps
because indoleamine 2,3 dioxygenase and tryptophan 2,3
dioxygenase oxidize tryptophan at the start of the
kynurenine pathway, increasing the kynurenine concen-
tration, which, in turn, results in increased KYNA forma-
tion. Since kynurenine 3-monooxygenase oxidizes
kynurenine to 3-HK and kynureninase hydrolyzes
kynurenine to anthranilic acid, they may compete with
the mKATs for the same substrate, kynurenine, thus
interfering with the KAT activity assay. The brain crude
extract sample also contains amino acids and α-keto
acids, which are substrates or inhibitors of four mKATs;
NADH and NADPH, which are cofactors of kynurenine
3-monooxygenase; and hemin, which functions as a cofa-
cor of both indoleamine 2,3 dioxygenase and tryptophan
2,3 dioxygenase. The presence of these substances and
other kynurenine pathway enzymes could directly affect
Figure 3 Thermal stability of four mKAT proteins at 65°C. a, Decay curves of mKAT I and mKAT II; b, mKAT III and mKAT IV.
Figure 4 Effect of pH on enzyme activity. The activities of recombinant mKATs at different pH values. a) mKAT I, b) mKAT II, c) mKAT III, d) mKAT IV.Han et al. BMC Biochemistry 2010, 11:19
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KAT activity assay by providing a co-substrate for KAT
enzymes or by competitively inhibiting the enzymes; or
they could indirectly change KAT activity by enhancing
the activity of kynureninase or kynurenine 3-monooxyge-
nase which competitively use kynurenine. To prevent or
decrease the interference from other kynurenine pathway
enzymes and brain chemicals, we first dialyzed the brain
crude sample with a 10 kDa molecular weight cutoff
membrane to eliminate possible substrates and inhibitors
of four KAT enzymes, and cofactors of other kynurenine
pathway enzymes from the sample. Herein, we demon-
strated all mKAT I, III, IV showed high resistance to heat
treatment, and mKAT II also showed noticeable activity
at 60°C. The Tm value of mKAT II is similar to that of
other mKATs except that its activity declines at 60°C,
which is lower than the Tm value. One possible reason
may be that the cofactor binding or dimer interaction is
disrupted at 60°C, without changing the absorbance at
280 nm significantly. Spectral changes in 280 nm caused
by protein denaturation are attributed to changes in the
environment of tyrosyl and tryptophyl side chains, which
are buried in the hydrophobic region of the native protein
Figure 5 Transamination activity of mKAT IV towards different 
amino acids with α-ketoglutarate or oxaloacetate as an amino 
group acceptor. The activity was quantified by the amount of gluta-
mate or aspartate produced in the reaction mixture. Oxaloacetate was 
only used for testing KAT activity with glutamate. 3-HK, 3-hydroxy-DL-
kynurenine, Kyn: kynurenine.
Figure 6 Effect of other amino acids on mKAT enzyme activities. The activities were quantified by the amount of KYNA produced in the reaction 
mixtures in 100 mM phosphate, pH 7.5. The mixture contains 5 mM kynurenine, 2 mM α-ketoglutarate (for mKAT I and III) or glyoxylate (for mKAT I and 
III), 5 mM other amino acid. The rate of KYNA production for each mKAT and different reaction mixture is shown in the figure. The bars labeled with 
stars (**P < 0.01, * P < 0.05) are significant different from the control (Kyn). Kyn: kynurenine, 3-HK, 3-hydroxy-DL-kynurenine. a) mKAT I, b) mKAT II, c) 
mKAT III, d) mKAT IV.
Figure 7 Transamination activity of mouse brain crude protein 
extract towards different α-ketoacids. The reaction mixture consists 
of 5 mM kynurenine, 2 mM α-keto acid, 40 μM PLP, 20 μg brain crude 
protein extract in 100 μL 100 mM phosphate buffer, pH 7.5. The mix-
ture was incubated at 38°C for 2 h and the reaction was stopped by 
adding an equal volume of 0.8 M formic acid. Measurement of KYNA 
was performed by HPLC with fluorometric detection at Exc. 340 nm 
and Em. 398 nm.Han et al. BMC Biochemistry 2010, 11:19
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molecule [41]. So the contribution of this spectral change
is made mainly by the disruption of secondary and ter-
tiary structures. The damage of quaternary structure may
not significantly contribute to this change unless there
are enough tyrosine and tryptophan residues involved in
dimerization. Comparing the crystal structures of the
four mKATs will help elucidate the mechanism. CD spec-
troscopy of mouse indoleamine 2,3 dioxygenase indicated
that the Tm value is 60°C, with a second intermediate Tm
at 44°C[42], and that rabbit indoleamine 2,3 dioxygenase
was not stable at 55°C[43]. Mosquito kynurenine 3-
monooxygenase shows very little activity at 55°C[44], but
there is little information about the thermal stability of
mammalian kynurenine 3-monooxygenases. Here, we did
notice that 3-HK formation is almost undetectable in the
reaction mixture at pH 7.5 after dialysis and heat treat-
ment of brain crude extract at 60°C for 15 min (not
shown). Apparently, kynurenine 3-monooxygenase was
d e a c t i v a t e d  e i t h e r  b y  t a k i n g  a w a y  a  c o f a c t o r  o r  b y
destroying the secondary, tertiary or quaternary structure
with heat treatment. Mammalian kynureninase has been
studied for its substrate specificity, pH optimum and
inhibition[45-47], but there is little information about its
thermal stability. The heat treatment of the crude extract
at 60°C for 15 min did decrease the anthranilic acid pro-
duction catalyzed by kynureninase (data not shown).
However, further study of the biochemical and biophysi-
cal properties of mouse kynureninase, indoleamine 2,3
dioxygenase, tryptophan 2,3 dioxygenase, and kynure-
nine 3-monooxygenase is needed in order to avoid the
interferences with the KAT specific assays from these
kynurenine pathway enzymes.
The purpose of comparing four different mKATs is to
find their unique characteristics and to develop a sensi-
tive and specific method to assay each mKAT. The assay
previously reported for KAT I using pyruvate as a co-sub-
strate at pH 9.5 [15] would also detect activity of the other
three KATs, because they all can use pyruvate as an
amino group acceptor and have activity at this pH[17,20].
In addition, pyruvate is not a favored co-substrate of KAT
I. The commonly used KAT II assay [15] is also problem-
atic because under the same assay conditions, KAT I and
III have detectable activity and KAT IV has high activ-
ity[17,20]. mKAT enzymes might not have exactly the
same properties as their human homologues, which have
been characterized previously [17,26], we used the same
protein expression system to produce all four mKATs and
obtained pH profiles, temperature preferences and
enzyme inhibitions for each individual enzyme. Some of
the results are interesting, e.g. optimum pH of mKAT II
(pH 6-8) is different from that of human KAT II (pH 7-9)
[26]. The characteristics of each mKAT, which could be
u s e d  f o r  d e v e l o p i n g  s p e c i f i c  a s s a y s  o f  f o u r  m K A T
enzymes are summarized for clarity in table 1. Based on
this information, we did preliminary tests to develop a
specific assay of each KAT. The assays for mKAT I and
mKAT II were shown to be highly specific; and the assay
methods for mKAT III and IV were shown to be specific
(Additional File 1).
Conclusions
This is the first kinetic characterization of the tempera-
ture and pH effects of the four mKAT enzymes. The
characteristics reported here could be used to develop
specific assay methods for each of the four murine KATs.
These specific assays could be used to identify which
KAT is affected in mouse models for research and to
develop small molecule drugs for prevention and treat-
ment of KAT-involved human diseases.
Methods
First-strand mouse brain cDNA synthesis and amplification 
of mKAT I, II, III and IV
Mouse brain was dissected from a euthanized male
C57BL/6 mouse and rapidly frozen in liquid nitrogen. A
mortar and a pestle, which were pre-cooled in liquid
nitrogen, were used to pulverize the frozen mouse brain
in the presence of additional liquid nitrogen. After the
Figure 8 Effect of four other amino acids on KAT activity of mouse 
brain crude protein extract. The reaction mixture consists of 5 mM 
kynurenine, 2 mM co-substrate (glyoxylate or α-ketoglutarate), 40 μM 
PLP, 5 mM other amino acid (putative inhibitor), 20 μg brain crude pro-
tein extract in 100 μL 100 mM phosphate buffer, pH 7.5 or 100 mM so-
dium borate buffer, pH 9. The mixture was incubated at 38°C for 2 h. 
The reaction was stopped by adding an equal volume of 0.8 M formic 
acid. Measurement of KYNA was performed by HPLC with fluorometric 
detection at Exc. 340 nm and Em. 398 nm. a) Results at pH 7.5 using α-
ketoglutarate as a co-substrate, b) Results at pH 9 using glyoxylate as a 
co-substrate.Han et al. BMC Biochemistry 2010, 11:19
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brain sample was pulverized to a fine powder, it was rap-
idly transferred into TRIZOL reagent (Gibco-BRL) for
the isolation of total RNA. Isolated total RNA was used to
synthesize first-stranded total brain cDNA. Oligonucle-
otide primers (Table 2) corresponding to individual
mKATs were synthesized and used for amplification of
their corresponding cDNA from the synthesized mouse
brain cDNA pool.
Expression and purification of recombinant mKATs
Each amplified sequence was cloned into an Impact™-CN
plasmid (New England Biolabs) for expression of a fusion
protein containing a chitin-binding domain. Transformed
E. coli cells were cultured at 37°C. After induction with
0.2 mM IPTG, the cells were cultured at 15°C for 24 hrs.
Two, six, three and three liters of cells were harvested as
the start materials of mKAT I, II, III and IV, respectively,
for affinity purification. The soluble fusion proteins were
applied to a column packed with chitin beads and subse-
quently hydrolyzed under reducing conditions. The affin-
ity purification resulted in the isolation of each individual
KAT at around 80% purity. Further purifications of the
recombinant KATs were achieved by DEAE-Sepharose,
Mono-Q and gel-filtration chromatography. The purified
recombinant KATs were concentrated to 10 mg ml-1 pro-
tein in 10 mM phosphate buffer (pH 7.5) containing 40
μM PLP and 10 mM β-mercaptoethanol using a Centri-
con YM-50 concentrator (Millipore). Protein concentra-
tion was tested by a protein assay kit from Bio-Rad
(Hercules, CA) using bovine serum albumin as a stan-
dard.
KAT Activity assay
The KAT activity assay was based on previously
described methods[17,20,26]. Briefly, a reaction mixture
of 100 μL, containing 5 mM L-kynurenine, 2 mM α-
ketoacids (α-ketoglutarate for mKAT II and IV, glyoxylate
for mKAT I and III), 40 μM PLP, and 5 μg of recombinant
protein, was prepared using 100 mM potassium phos-
phate buffer (pH 7.5). This reaction mixture will be iden-
tified hereafter as the typical mixture. The mixture was
incubated for 15 min at 38°C, and the reaction was
stopped by adding an equal volume of 0.8 M formic acid.
The supernatant of the reaction mixture, obtained by
centrifugation at 15,000 g for 10 min at room tempera-
ture, was analyzed for the product, KYNA, by high-per-
formance liquid chromatography (HPLC) with ultraviolet
detection at 330 nm.
Substrate specificity of mKAT IV
The transamination activity of mKAT IV to other amino
acids was tested using an assay mixture containing 10
mM of an amino acid, 10 mM α-ketoglutarate (or 10 mM
oxaloacetate for the activity assay of glutamate), 40 μM
PLP, 100 mM phosphate buffer, pH 7.5, and 5 μg enzyme
in a total volume of 100 μl. The mixture was incubated for
15 min at 38°C and stopped by adding an equal amount of
absolute ethanol. The product was quantitated based on
the detection of o-phthaldialdehyde thiol (OPT)-amino
acid product conjugate by HPLC with electrochemical
detection after their corresponding reaction mixtures
were derivatized by OPT reagent[39].
Effect of pH and temperature on recombinant mKAT 
enzymes
To determine the effect of buffer pH on the activity of the
four mKATs, a buffer mixture consisting of 100 mM
phosphate and 100 mM boric acid was prepared and the
pH of the buffer was adjusted to 6.0, 7.0, 8.0, 9.0, 10.0 and
11.0. The substrates and PLP were used in the same con-
Table 1: Major differences of four mKAT enzymes
mKAT I mKAT II mKAT III mKAT IV
Tm (°C) 69.8 65.9 64.8 66.5
t1/2 (min) 69.7 27.4 3.9 6.5
pKa 7.6 5.7 8.7 6.9
pH optima 9 7-8 9 8
Specific
co-substrate
α-ketobutyrate α-ketoglutarate α-ketobutyrate α-ketoglutarate
Inhibitor Indole-3-propionic 
acid
methionine aspartate
Tm: The midpoint temperature of the protein melting; t1/2: half life value at 65°CHan et al. BMC Biochemistry 2010, 11:19
http://www.biomedcentral.com/1471-2091/11/19
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centrations as described above for the specific activity
assay. pKa and pKb values of two proteins were calculated
based on the data of specific activities versus pH values
using SigmaPlot Enzyme Kinetics Module (SPSS, San
Jose, CA). To determine the effect of temperature on the
four mKAT enzymes, the typical reaction mixture in 100
μL of phosphate buffer (pH 7.5) was incubated at temper-
atures ranging from 20 - 80°C for 15 min. During the mix-
ture preparations, enzymes were held at same
temperature for 5 min.
In Tm value tests, enzymes were diluted in 100 mM
potassium phosphate buffer, pH 7.5. Each mKAT was
then heated at various temperatures for 5 min using a
thermal cycler (MJ Research, Waltham, MA). The absor-
bance at 280 nm was detected using a UV-Visible spec-
trophotometer (Hitachi, Tokyo, Japan). The Tm value for
each enzyme was calculated by fitting the equation to the
recorded data using the standard curve analysis function
in SigmaPlot Enzyme Kinetics Module (SPSS, San Jose,
CA).
The thermal stability was determined by studying ther-
mal inactivation of enzyme incubated in 50 mM phos-
phate buffer, pH 7.5, at 65°C using a thermal cycler (MJ
Research, Waltham, MA). Periodically, samples of the
incubated enzymes were removed, chilled immediately by
mixing with a cold phosphate buffer, 50 mM, pH 7.5. The
remaining activity was assayed within 10 min using same
method described above. Rate constant (k) was calculated
based on the equation
where e is a mathematical constant, approximately
equal to 2.718281828, t is time (min), [A] is mole of the
active enzyme left, [A0] is mole of the original protein. t1/2
is calculated based on the equation
where k is the rate constant (min-1), and ln is the natural
logarithm.
Effect of other amino acids on four mKAT activities
To determine the effect of other amino acids on mKAT
enzymes, each amino acid was incorporated into 100 μL
of the typical reaction mixture (5 mM kynurenine, 2 mM
co-substrate, 100 mM phosphate buffer at pH 7.5) at a
final concentration of 5 mM and the enzyme activity was
assayed in the same manner as described for the KAT
activity assay.
KAT activity assay for mouse brain crude proteins
Five to seven week old BALB/c mice were used. All exper-
imental procedures were approved by the Institutional
Animal Care and Use Committee of Virginia Polytechnic
Institute and State University and met or exceeded
requirements of the Public Health Service/National Insti-
tutes of Health and the Animal Welfare Act. The animals
were housed in groups of four to five per cage, in a room
with controlled light/dark cycle (12 h light/12 h dark),
and were given free access to laboratory chow and tap
water. Two females and two males were sacrificed; the
brains were immediately removed and frozen in liquid
nitrogen. The brains were ground in liquid nitrogen, and
the powder was transferred into 10 ml of 5 mM Tris-ace-
tate buffer containing 40 μM PLP and 10 mM β-mercap-
toethanol (extract buffer) at pH 8.0, and mixed well. The
mixture was centrifuged at 20,000 g, 4°C, for 20 min. The
supernatant was collected and dialyzed overnight at 4°C
against the protein extract buffer with a 10 kDa molecular
[] [ ] AA e
kt =
−
0
tk 12 2 / ln / =
Table 2: Oligonucleotide primers used for amplification of mKATs
Genes Nucleotide Sequences Restriction Sites
mKAT I (NP_765992) 5'-AAAACATATGTCCAAACAGCTGCAGGCTC-3'
5'-AAAACTCGAGTCAGGCTTGGGGCTCTCCTT-3'
Nde I
Xho I
mKAT II (NP_035964) 5'-AAAACATATGAATTACTCACGGTTCCTCACT-3'
5'-AAAACTCGAGTCATAAAGACTCTTTTATCAGTTGGGC-3'
Nde I
Xho I
mKAT III (AAQ15190) 5'-AAAAGAATGCTGCTTTGAAATTCAAAAACG-3'
5'-AAAAGAATTCTCAGTTCCAGGCCCTGAAGA-3'
Bsm I
Eco RI
mKAT IV (NP_034455) 5'-AAAACATATGGCCAGAGCCAGCTCCT-3'
5'-AAAACTCGAGTTACTTGGTGACCTGGTGAATG-3'
Nde I
Xho I
Note: The restriction sites are underlined.Han et al. BMC Biochemistry 2010, 11:19
http://www.biomedcentral.com/1471-2091/11/19
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weight cutoff membrane. The dialyzed brain crude pro-
tein extract was used for KAT activity assay. The crude
protein concentration was tested by a protein assay kit
from Bio-Rad (Hercules, CA) using bovine serum albu-
min as a standard. We used 20 μg brain crude protein in
100 μl of the same typical reaction mixture as was used in
the recombinant protein KAT activity assay. The mixture
was incubated at 38°C for 2 h. Since the amount of KYNA
formed by the brain crude extract in reaction mixture is
quite low compared to that formed by the recombinant
protein, measurement of KYNA was performed by HPLC
with fluorometric detection according to the method
described by Baran and Kepplinger[48]. The fluorescence
detector was set at an excitation wavelength of 340 nm
and an emission wavelength of 398 nm. The substrate
specificity for α-keto acids and the inhibition of different
amino acids of the brain crude extract were also tested.
The inhibition was tested at both pH 7.5 (100 mM phos-
phate buffer) and pH 9 (100 mM sodium borate buffer).
Additional material
Abbreviations
3-HK: 3-hydroxy-DL-kynurenine; AADAT: aminoadipate aminotransferase; ASAT:
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